Anthony R. Chase, Director at Sarepta Therapeutics, Inc. (SRPT), sold 10,000 shares at $29.70 ($295K) on 2012-11-28, disclosed to the SEC on 2012-11-29.
Open-market sale of $295k SRPT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.04 | 1,100 | $32K | 10.8% |
| 2 | $28.17 | 1,600 | $45K | 15.3% |
| 3 | $29.70 | 5,700 | $169K | 57.5% |
| 4 | $30.21 | 1,600 | $48K | 16.4% |
| Total | $29.46 avg | 10,000 | $295K | 100% |
| Filing → |
| LYB | BUY | 2023-07-10 | $3K | — | Filing → |
| APC | BUY | 2017-05-18 | $200K | — | Filing → |
| APC | BUY | 2014-09-02 | $189K | — | Filing → |